Martine Rothblatt

2014

In 2014, Martine Rothblatt earned a total compensation of $33.2M as Chairman and Chief Executive Officer at United Therapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,633,033
Non-Equity Incentive Plan$1,073,981
Option Awards$29,460,128
Salary$1,024,524
Other$23,263
Total$33,214,929

Rothblatt received $29.5M in option awards, accounting for 88.70% of the total pay in 2014.

Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $1M in salary and $23.3K in other compensation.

Overall ranking

Ranking

40

out of 12,947
Percentile100th

Martine Rothblatt's 2014 compensation ranked 40th out of 12,947 executive pay records tracked by us this year.

Rothblatt earned more than 99.7% of all executives tracked by us in 2014.

Ranking in industry group

Industry groupDrugs
Ranking

7

out of 1,319
Percentile100th

In the industry group of Drugs, Rothblatt's pay ranked 7th out of 1,319 executive pay records tracked by us in 2014.

Rothblatt earned more than 99.5% of executives in this group.

Source: SEC filing on April 28, 2017.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2014.

2014

Roger Jeffs

United Therapeutics

Chief Executive Officer

2014

John Ferrari

United Therapeutics

Chief Financial Officer

2014

Paul Mahon

United Therapeutics

General Counsel

News

In-depth

You may also like